Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 18108
Country/Region: Mozambique
Year: 2017
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USDOD
Total Funding: $1,871,355 Additional Pipeline Funding: $1,750,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $327,007
Care: TB/HIV (HVTB) $96,109
Care: Pediatric Care and Support (PDCS) $8,694
Laboratory Infrastructure (HLAB) $41,315
Health Systems Strengthening (OHSS) $20,657
Prevention: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $6,988
Treatment: Adult Treatment (HTXS) $1,360,129
Treatment: Pediatric Treatment (PDTX) $10,456
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD By Test Result: Positive 2018 6,002
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2018 1,632
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2018 33
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 5,216
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 580
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 3,597
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 400
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 90
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 10
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 90
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 10
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Negative 2018 7,329
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Female, Positive 2018 803
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Negative 2018 8,655
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: 15+, Male, Positive 2018 743
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: <15, Female, Negative 2018 123
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: <15, Female, Positive 2018 14
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: <15, Male, Negative 2018 123
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Index Mod: <15, Male, Positive 2018 14
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 2,468
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 237
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 1,545
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 386
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 1,066
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 266
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 27
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 7
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 27
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 7
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 128
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 14
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 2,431
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 270
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 93
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 93
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 62
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 62
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 5,347
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 937
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 5,384
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 835
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 91
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 16
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 91
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 16
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 348
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 11
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 6,617
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 205
HTC_TST_DSD Sum of Test Result disaggregates 2018 6,002
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 214
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 212
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 2
PMTCT_STAT_DSD By Age (Denominator): Unknown Age 2018 2,847
PMTCT_STAT_DSD By Number of new negative: Unknown Age 2018 2,468
PMTCT_STAT_DSD By Number of new positives: Unknown Age 2018 237
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 2,705
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 252
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 168
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 420
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 420
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2018 1,483
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2018 1,320
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2018 52
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2018 67
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2018 1,187
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2018 1,056
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2018 41
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2018 54
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 2,338
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 2,922
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 372
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 249
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 621
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 1,338
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2018 7,063
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2018 6,287
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2018 246
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2018 319
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 13,916
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2018 13,350
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2018 565
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2018 13,915
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2018 2,242
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2018 2,235
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2018 127
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2018 96
TX_NEW_DSD By Age/Sex: <1 2018 214
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 4,701
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2018 4,700
TX_PVLS_DSD 15+, Undocumented Test Indication, Female 2018 1,159
TX_PVLS_DSD 15+, Undocumented Test Indication, Male 2018 1,264
TX_PVLS_DSD <15, Undocumented Test Indication, Female 2018 39
TX_PVLS_DSD <15, Undocumented Test Indication, Male 2018 51
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 1,448
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,448
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,580
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,580
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 49
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 49
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 64
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 64
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 6,283
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,159
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,264
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 39
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 51
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 907
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 725
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,502
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,002
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 39
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 31
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 26
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 21
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 2,779
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 3,474
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2018 172
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2018 223
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2018 4,944
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2018 4,401
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2018 9,741
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 3,896
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,978
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 1,760
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Female 2018 69
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Male 2018 89